Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$88.96 - $112.35 $37,363 - $47,187
420 Added 9.82%
4,697 $433,000
Q2 2023

Aug 11, 2023

BUY
$102.58 - $129.66 $56,521 - $71,442
551 Added 14.79%
4,277 $461,000
Q1 2023

May 15, 2023

SELL
$122.57 - $153.67 $75,380 - $94,507
-615 Reduced 14.17%
3,726 $464,000
Q4 2022

Feb 14, 2023

BUY
$118.43 - $186.05 $514,104 - $807,643
4,341 New
4,341 $0

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.3B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Capital Group Investment Management Pte. Ltd. Portfolio

Follow Capital Group Investment Management Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Investment Management Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Investment Management Pte. Ltd. with notifications on news.